Glow Blend (70 mg (50/10/10))
GLOW Blend is a tri-peptide co-lyophilized research formulation uniting GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg) to study synergistic collagen synthesis, angiogenesis, and fibroblast migration.
Scientific Profile & Research Key Points: Glow Blend
GLOW Blend is a tri-peptide co-lyophilized research formulation uniting GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 (10 mg) to study synergistic collagen synthesis, angiogenesis, and fibroblast migration.
Active Batch Release Specifications (Lot SL-2026-127)
Analytical release verification for current Glow Blend (70 mg (50/10/10)) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-127 | 2026-10-28 | Gradient RP-HPLC (Multi-Peak Resolution) + ESI-MS | ≥99.0% (Resolved Constituent Peaks) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile 0.9% Bacteriostatic Water (3.0 mL); gently swirl to clear blue solution
Temperature & Stability
Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 28 days.
Glow Blend — Technical Questions & Answers
How are the individual constituents of Glow Blend verified in a single vial?
Because co-lyophilized blends contain multiple sequences with distinct retention times, Lot SL-2026-127 is evaluated via gradient RP-HPLC to resolve each constituent peak independently, paired with ESI-MS mass confirmation (403.93 / 1419.53 / 4963.50 g/mol).
How do you calculate working stock aliquots for a multi-component blend like Glow Blend?
Calculate each active constituent separately based on its labeled mass ratio (70 mg (50/10/10)) divided by total diluent volume added. For example, adding 2.0 mL of sterile diluent yields proportional mg/mL concentrations for every component simultaneously.
What primary pathways are investigated using Glow Blend?
Investigators study Glow Blend in Extracellular matrix remodeling, VEGFR2 angiogenesis & G-actin motility models. Primary published literature context: Pickart L. (2018), Chang C.H. (2011) & Goldstein A.L. (2012) — Multi-pathway dermal & vascular remodeling models. All lots are supplied strictly for in-vitro laboratory experimentation.
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
GHK-Cu: Biochemistry of the Gly-His-Lys Copper Complex in Gene Expression and Tissue Remodeling
A biochemical review of the human tripeptide copper complex GHK-Cu. Epigenetic gene resetting, metalloproteinase modulation, collagen/elastin synthesis, and analytical HPLC verification.
Glutathione: The γ-Glutamyl Isopeptide Bond, Redox Potentials, and GSSG Dimerization
A molecular analysis of reduced Glutathione (GSH) vs oxidized Glutathione Disulfide (GSSG). Why the unusual gamma-peptide bond protects against intracellular peptidases.
KLOW Blend: Multi-Peptide Co-Lyophilization and HPLC Chromatography of Complex Mixtures
Analyzing complex multi-compound formulations (GHK-Cu, BPC-157, TB-500, KPV). How co-lyophilization affects individual peptide stability, retention peaks, and analytical verification.